✦ LIBER ✦

Targeting Bone as a Therapy for Myeloma

✍ Scribed by Ping Wu; Gareth J. Morgan

Book ID: 107648002
Publisher: Springer Netherlands
Year: 2011
Tongue: English
Weight: 340 KB
Volume: 4
Category: Article
ISSN: 1875-2292
DOI: 10.1007/s12307-011-0079-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone marrow microenvironment and the ide

Bone marrow microenvironment and the identification of new targets for myeloma therapy

✍ Podar, K; Chauhan, D; Anderson, K C 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 351 KB

Interleukin-6, a new target for therapy

Interleukin-6, a new target for therapy in multiple myeloma?

✍ M. H. J. van Oers; H. C. T. van Zaanen; H. M. Lokhorst 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 550 KB

Thalidomide as initial therapy for early

Thalidomide as initial therapy for early-stage myeloma

✍ Rajkumar, S V; Gertz, M A; Lacy, M Q; Dispenzieri, A; Fonseca, R; Geyer, S M; It 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

Thalidomide as anti-inflammatory therapy

Thalidomide as anti-inflammatory therapy for multiple myeloma

✍ Mehta, P; Hussein, M 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

Oncolytic Coxsackievirus A21 as a novel

Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma

✍ Gough G. Au; Lisa F. Lincz; Arno Enno; Darren R. Shafren 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 752 KB

Telomerase as a possible target for anti

Telomerase as a possible target for anticancer therapy

✍ Chantal Autexier 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Telomeres, the termini of chromosomes, provide essential stability to linear eukaryotic chromosomes. The enzyme telomerase is one mechanism that maintains telomeres, and is activated in 85% of human cancer cells. New studies on peptide nucleic acids (PNAs) that inhibit telomerase have demonstrated t